Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 141 citing articles:

The effects of the COVID-19 pandemic on community respiratory virus activity
Eric J. Chow, Timothy M. Uyeki, Helen Y. Chu
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 445
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
Marta Bertran, Zahin Amin‐Chowdhury, Carmen Sheppard, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 8, pp. 1669-1672
Open Access | Times Cited: 86
Epidemiology of Respiratory Infections during the COVID-19 Pandemic
Nicola Principi, Giovanni Autore, Greta Ramundo, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1160-1160
Open Access | Times Cited: 74
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study
Marta Bertran, Joshua C D'Aeth, Fariyo Abdullahi, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 546-556
Open Access | Times Cited: 42
Impact of COVID-19 pandemic on routine immunization
Martin O. C. Ota, Selim Badur, L. Mazzotti, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 2286-2297
Open Access | Times Cited: 91
Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021
Stephanie Perniciaro, Mark van der Linden, Daniel M. Weinberger
Clinical Infectious Diseases (2022) Vol. 75, Iss. 7, pp. 1149-1153
Open Access | Times Cited: 61
Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
Joseph A. Lewnard, Katia Bruxvoort, Heidi Fischer, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 10, pp. 1710-1720
Open Access | Times Cited: 58
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
Elise Tessier, Helen Campbell, Sonia Ribeiro, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C. Urban, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 43
Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic
Hung-Jen Tang, Chih‐Cheng Lai, Chien‐Ming Chao
Antibiotics (2022) Vol. 11, Iss. 3, pp. 315-315
Open Access | Times Cited: 40
Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
Jing Shen, Najida Begum, Yara Ruiz García, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 38
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
Ashley Losier, Gayatri Gupta, Mario Caldararo, et al.
Clinics in Chest Medicine (2023) Vol. 44, Iss. 2, pp. 407-423
Open Access | Times Cited: 23
Revolutionizing Mushroom processing: Innovative techniques and technologies
Sangeeta, Dhriti Sharma, Seema Ramniwas, et al.
Food Chemistry X (2024) Vol. 23, pp. 101774-101774
Open Access | Times Cited: 7
Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States
Liping Huang, Matt Wasserman, Lindsay R. Grant, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4700-4708
Open Access | Times Cited: 33
A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable
William Cookson, Miriam F. Moffatt, Garth Rapeport, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 11, pp. 1271-1280
Open Access | Times Cited: 30
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014–2020
Namrata Prasad, Julia Rhodes, Li Deng, et al.
The Journal of Infectious Diseases (2023) Vol. 227, Iss. 7, pp. 907-916
Open Access | Times Cited: 20
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps
Anabelle Wong, Laura Andrea Barrero Guevara, Elizabeth Goult, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 3, pp. e1011167-e1011167
Open Access | Times Cited: 19
Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020–2022
Leah J. Ricketson, James D. Kellner
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1333-1333
Open Access | Times Cited: 16
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 15
Serotype, antibiotic susceptibility and whole-genome characterization of Streptococcus pneumoniae in all age groups living in Southwest China during 2018–2022
Chenglin Miao, Ziyi Yan, Chunmei Chen, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Alane Izu, Eleonora A.M.L. Mutsaerts, Courtney P. Olwagen, et al.
Expert Review of Vaccines (2025) Vol. 24, Iss. 1, pp. 121-127
Open Access
Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom
Rachel J. Oidtman, Giulio Meleleo, Oluwaseun Sharomi, et al.
Infectious Diseases and Therapy (2025)
Open Access
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age
Tosin Omole, Enrique Pelayo, Aaron S. Weinberg, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 192-192
Open Access
Comparison of Streptococcus pneumoniae nasopharyngeal colonization, serotype-specific and protein-specific antibody and cytokine levels in young children prior to, during and post COVID-19 pandemic
Naoko Fuji, Eduardo Gonzalez, Frank N. Salamone, et al.
Vaccine (2025) Vol. 54, pp. 126954-126954
Closed Access
European Pediatric Societies Call for an Implementation of Regular Vaccination Programs to Contrast the Immunity Debt Associated to Coronavirus Disease-2019 Pandemic in Children
Robert Cohen, Massimo Pettoello‐Mantovani, Eli Somekh, et al.
The Journal of Pediatrics (2021) Vol. 242, pp. 260-261.e3
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top